Skip to search.
 All Ordinaries Down 0.31%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
2.09 Down 0.04(1.65%) 05:11 - Nasdaq Real-Time Price
Add to Portfolio
Prev Close:2.12
Open:2.09
Bid:2.08 x 4700
Ask:2.09 x 3200
1y Target Est:8.80
Beta:2.58
Next Earnings Date: 6-Aug-15SNTA Earnings announcement
Day's Range:2.06 - 2.13
52wk Range:1.85 - 4.19
Volume:632,131
Avg Vol (3m):1,199,580
Market Cap:280.27M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTADown 1.65%280.27M
INFIDown 1.26%423.23M
NVSUp 0.29%251.30B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.74
Quarterly EPS Est (Jun-15) :-0.18
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback